Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt repayments

Growth Metrics

Others

Odyssey Health (ODYY) Cash from Investing Activities (2016)

Odyssey Health has reported Cash from Investing Activities over the past 1 years, most recently at -$3310.0 for Q3 2016.

For Q3 2016, Cash from Investing Activities changed N/A year-over-year to -$3310.0; the TTM value through Jul 2020 reached -$3310.0, changed N/A, while the annual FY2025 figure was $69787.0, 93.02% down from the prior year.
Cash from Investing Activities for Q3 2016 was -$3310.0 at Odyssey Health.
Over five years, Cash from Investing Activities peaked at -$3310.0 in Q3 2016 and troughed at -$3310.0 in Q3 2016.